miRNAシーケンシングおよびアッセイの市場規模、シェア、動向分析レポート：製品・サービス別、技術別、ワークフロー別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年

miRNAシーケンシングおよびアッセイ市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のmiRNAシーケンシングおよびアッセイ市場規模は、2023年から2030年にかけて13.3%のCAGRを記録し、2030年までに8億2,350万米ドルに達すると予測されています。

例えば、miRNAは、がん（子宮頸がん、卵巣がん、乳がん）、敗血症、心血管疾患、神経系疾患の予後や診断のバイオマーカーとして効率的に使用できることが、様々な調査研究で述べられています。このように、miRNAの配列解析は、臨床疾患における遺伝子制御解析に大いに利用されています。例えば、2022年3月にfrontiers誌に掲載された論文では、血液ベースのmiRNAバイオマーカーは、脳ベースのmiRNA発現との相関に使用できると述べられています。

COVID-19のパンデミックは、コロナウイルスの存在を特定するためのmiRNAの利用を強化しました。miRNAバイオマーカーは、COVID-19の重症度を示し、診断するために応用される可能性があります。miRNAは免疫反応、ウイルス増殖、感染細胞の複製、心血管機能障害に重要な役割を果たしています。さらに、COVID-19患者から回収された血漿には抗体と抗ウイルスmiRNAが豊富に含まれています。これはCOVID-19感染患者の治療に利用されています。このため、ウイルスだけでなく患者からのmiRNA配列解析に焦点を当てた調査が増加しています。

PerkinElmer Inc.、Illumina, Inc.、Qiagenなどの著名企業は、いくつかの臨床用途向けに革新的なシーケンシング製品を提供しています。さらに、これらの企業は、研究研究におけるシーケンシングアプリケーションを拡大するために、研究機関といくつかの戦略的イニシアティブを締結しています。例えば、韓国のバイオ医薬品企業であるBIORCHESTRAは、2022年1月にSK Biopharmaceuticalsと提携契約を締結し、miRNAを標的とする新規治療化合物の研究開発を加速させています。

市場の主なプレーヤーは、高い特異性と再現性を備えた新しいツール、機器、キットの開発に携わっており、これが市場の成長を後押ししています。例えば、2019年10月、TriLink BioTechnologies社はCleanTagキット用の2つのプライマーセットを発表しました。サーモフィッシャーサイエンティフィックのシーケンサープラットフォームは、これらの新しいIon Torrent Convertバーコードプライマーセットを使用して小分子RNAライブラリを調製できます。このような発売は市場の成長を後押しすると期待されます。

miRNAシーケンシングおよびアッセイ市場レポートハイライト：

• 製品セグメントは2022年に約80%の最大収益シェアで市場を独占しました。これは、特定の用途向けに幅広い消耗品、キット、機器を提供する主要企業が複数存在するためです。
• 技術別では、合成によるシーケンシングセグメントが2022年に32%を超える最大の収益シェアを占め、市場を独占しました。これは、迅速なターンアラウンドタイム、高感度、高スループットによるものです。さらに、腫瘍組織の変異検出において重要な役割を果たしており、個別化治療の開発に役立っています。
• ワークフロー別では、シーケンシングセグメントが2022年に50％を超える最大の収益シェアで市場を独占し、ワークフローの中で最も重要なステップであることから、予測期間中に14.1％のCAGRで最速の成長が見込まれています。生物学的研究やいくつかの疾患診断において重要な研究ツールとなっています。
• 用途別では、がん分野が市場を独占し、2022年には35%以上の最大収益シェアを占めました。新しい治療法を開発するためにがんの予後と診断を研究するバイオマーカーとしてmiRNAを使用するがんのいくつかの進行中の研究が、このセグメントの成長に寄与しています。
• 最終用途別では、研究・学術機関分野が市場を独占し、2022年には50%を超える最大の収益シェアを占めました。この成長は、学術機関がmiRNAシーケンシング技術を使用して行う研究開発研究の増加に起因しています。
• アジア太平洋地域は、予測期間中に15.4%のCAGRで最速の成長が見込まれています。これは、ヘルスケアインフラの成長、対象人口の増加、アンメットニーズの高さによるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 miRNAシーケンシングおよびアッセイの市場変数、動向および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 普及と成長の見通しマッピング
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• miRNAシーケンシングおよびアッセイ市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 miRNAシーケンシングおよびアッセイ：製品とサービスの推定・動向分析

• miRNAシーケンシングおよびアッセイ市場：重要なポイント
• miRNAシーケンシングおよびアッセイ市場：動向と市場シェア分析、2022年および2030年
• 製品
  • 製品市場推計・予測、2018年から2030年まで
  • ライブラリー準備キット
  • シーケンシング用消耗品
  • 機器
• サービス
  • サービス市場推計・予測、2018年から2030年まで

第5章 miRNAシーケンシングおよびアッセイ：技術の推定・動向分析

• miRNAシーケンシングおよびアッセイ市場：重要なポイント
• miRNAシーケンシングおよびアッセイ市場：動向と市場シェア分析、2022年および2030年
• 合成による配列決定
• オリゴヌクレオチドのライゲーションと検出によるシーケンシング（SOLiD）
• ナノポアシーケンシング
• サンガー配列決定
• 単一分子リアルタイム（SMRT）シーケンシング

第6章 miRNAシーケンシングおよびアッセイ：ワークフローの推定・動向分析

• miRNAシーケンシングおよびアッセイ市場：重要なポイント
• miRNAシーケンシングおよびアッセイ市場：動向と市場シェア分析、2022年および2030年
• ライブラリの準備
  • 図書館準備市場推計・予測、2018年から2030年まで
• シーケンシング
  • シーケンシング市場推計・予測、2018年から2030年まで
• データの分析と保存
  • データ分析およびストレージ市場推計・予測、2018年から2030年まで

第7章 miRNAシーケンシングおよびアッセイ：用途の推定・動向分析

• miRNAシーケンシングおよびアッセイ市場：重要なポイント
• miRNAシーケンシングおよびアッセイ市場：動向と市場シェア分析、2022年および2030年
• がん
• ポリグルタミン病
• 自己免疫疾患
• 統合失調症
• その他

第8章 miRNAシーケンシングおよびアッセイ：最終用途の推定・動向分析

• miRNAシーケンシングおよびアッセイ市場：重要なポイント
• miRNAシーケンシングおよびアッセイ市場：動向と市場シェア分析、2022年および2030年
• 製薬およびバイオテクノロジー産業
  • 製薬およびバイオテクノロジー業界の市場推計・予測、2018年から2030年まで
• 研究および学術機関
  • 研究および学術機関の市場推計・予測と2018年から2030年
• その他
  • その他の市場推計・予測、2018年から2030年まで

第9章 miRNAシーケンシングおよびアッセイ：地域の推定・動向分析

• 地域別の見通し
• 地域別のmiRNAシーケンシングおよびアッセイ市場：重要なポイント
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第10章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 市場参入企業の分類
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • QIAGEN
  • PerkinElmer, Inc
  • Abcam plc
  • New England Biolabs
  • Takara Bio Inc.
  • Lexogen GmbH
  • Norgen Biotek Corp.
  • Maravai LifeSciences
  • HTG Molecular Diagnostics, Inc.
  • Meridian Bioscience, Inc.
  • System Biosciences, LLC

List of Tables

• Table 1 List of abbreviations
• Table 2 North America miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 3 North America miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 4 North America miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 5 North America miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 6 North America miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 7 North America miRNA sequencing and assay market, by region, 2018 - 2030 (USD Million)
• Table 8 U.S. miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 9 U.S. miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 10 U.S. miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 11 U.S. miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 12 U.S. miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 13 Canada miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 14 Canada miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 15 Canada miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 16 Canada miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 17 Canada miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 18 Europe miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 19 Europe miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 20 Europe miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 21 Europe miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 22 Europe miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 23 Europe miRNA sequencing and assay market, by region, 2018 - 2030 (USD Million)
• Table 24 Germany miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 25 Germany miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 26 Germany miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 27 Germany miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 28 Germany miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 29 UK miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 30 UK miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 31 UK miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 32 UK miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 33 UK miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 34 France miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 35 France miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 36 France miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 37 France miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 38 France miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 39 Italy miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 40 Italy miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 41 Italy miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 42 Italy miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 43 Italy miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 44 Spain miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 45 Spain miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 46 Spain miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 47 Spain miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 48 Spain miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 49 Sweden miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 50 Sweden miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 51 Sweden miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 52 Sweden miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 53 Sweden miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 54 Norway miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 55 Norway miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 56 Norway miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 57 Norway miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 58 Norway miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 59 Denmark miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 60 Denmark miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 61 Denmark miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 62 Denmark miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 63 Denmark miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 66 Asia Pacific miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 67 Asia Pacific miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 68 Asia Pacific miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 69 Asia Pacific miRNA sequencing and assay market, by region, 2018 - 2030 (USD Million)
• Table 70 China miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 71 China miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 72 China miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 73 China miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 74 China miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 75 Japan miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 76 Japan miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 77 Japan miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 78 Japan miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 79 Japan miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 80 India miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 81 India miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 82 India miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 83 India miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 84 India miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 85 Australia miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 86 Australia miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 87 Australia miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 88 Australia miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 89 Australia miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 90 Thailand miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 91 Thailand miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 92 Thailand miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 93 Thailand miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 94 Thailand miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 95 South Korea miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 96 South Korea miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 97 South Korea miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 98 South Korea miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 99 South Korea miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 100 Latin America miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 101 Latin America miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 102 Latin America miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 103 Latin America miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 104 Latin America miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 105 Latin America miRNA sequencing and assay market, by region, 2018 - 2030 (USD Million)
• Table 106 Brazil miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 107 Brazil miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 108 Brazil miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 109 Brazil miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 110 Brazil miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 111 Mexico miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 112 Mexico miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 113 Mexico miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 114 Mexico miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 115 Mexico miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 116 Argentina miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 117 Argentina miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 118 Argentina miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 119 Argentina miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 120 Argentina miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 121 Middle East and Africa miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 122 Middle East and Africa miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 123 Middle East and Africa miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 124 Middle East and Africa miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 125 Middle East and Africa miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 126 Middle East and Africa miRNA sequencing and assay market, by region, 2018 - 2030 (USD Million)
• Table 127 South Africa miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 128 South Africa miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 129 South Africa miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 130 South Africa miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 131 South Africa miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 132 Saudi Arabia miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 133 Saudi Arabia miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 134 Saudi Arabia miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 135 Saudi Arabia miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 136 Saudi Arabia miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 137 UAE miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 138 UAE miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 139 UAE miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 140 UAE miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 141 UAE miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
• Table 142 Kuwait miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
• Table 143 Kuwait miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
• Table 144 Kuwait miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
• Table 145 Kuwait miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
• Table 146 Kuwait miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 MiRNA sequencing and assay: Market outlook
• Fig. 9 MiRNA sequencing and assay: Competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 MiRNA sequencing and assay market driver impact
• Fig. 14 MiRNA sequencing and assay market restraint impact
• Fig. 15 MiRNA sequencing and assay market strategic initiatives analysis
• Fig. 16 MiRNA sequencing and assay market: Product & service movement analysis
• Fig. 17 MiRNA sequencing and assay market: Product & service outlook and key takeaways
• Fig. 18 Products market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Library preparation kits market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Sequencing consumables market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 MiRNA sequencing and assay market: Technology movement analysis
• Fig. 24 MiRNA sequencing and assay market: Technology outlook and key takeaways
• Fig. 25 Sequencing by synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Sequencing by oligonucleotide ligation and detection (solid) market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Nanopore sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Sanger sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Single molecule real-time (SMRT) sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 MiRNA sequencing and assay market: Workflow movement analysis
• Fig. 31 MiRNA sequencing and assay market: Workflow outlook and key takeaways
• Fig. 32 Library preparation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Data analysis & storage market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 MiRNA sequencing and assay market: Application movement analysis
• Fig. 36 MiRNA sequencing and assay market: Application outlook and key takeaways
• Fig. 37 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Polyglutamine diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Autoimmune diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Schizophrenia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 MiRNA sequencing and assay market: End use movement analysis
• Fig. 43 MiRNA sequencing and assay market: End use outlook and key takeaways
• Fig. 44 Pharmaceutical & biotechnology industry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Research and academic institutes market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Global MiRNA sequencing and assay market: Regional movement analysis
• Fig. 48 Global MiRNA sequencing and assay market: Regional outlook and key takeaways
• Fig. 49 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

miRNA Sequencing And Assay Market Growth & Trends:

The global miRNA sequencing and assay market size is expected to reach USD 823.5 Million by 2030, registering a CAGR of 13.3% from 2023 to 2030, according to a new report by Grand View Research, Inc.. For instance, various research studies stated that miRNAs can be efficiently used as biomarkers in the prognosis and diagnosis of cancer (cervical, ovarian, and breast), sepsis, cardiovascular diseases, and nervous system conditions. Thus, miRNA sequence analysis is significantly employed for gene regulation analysis in clinical disorders. For instance, an article published in frontiers, in March 2022, stated that blood-based miRNA biomarkers could be used to correlate brain-based miRNA expression.

The COVID-19 pandemic has enhanced the usage of miRNA to identify the presence of coronavirus. miRNA biomarkers have potential application to indicate and diagnose the COVID-19 severity. It plays a significant role in immune response, viral proliferation, replication of infected cells, and cardiovascular dysfunction. In addition, plasma recovered from COVID-19 patients is rich in antibodies and antiviral miRNAs. It has been utilized to treat COVID-19-infected patients. This has resulted in increasing research studies that focus on the miRNA sequence analysis from the patient as well as the virus.

Prominent players such as PerkinElmer Inc.; Illumina, Inc.; and Qiagen offer innovative sequencing products for several clinical applications. Furthermore, these companies have entered into several strategic initiatives with research institutes to expand the sequencing application in research studies. For instance, in January 2022, BIORCHESTRA, a South Korean biopharmaceutical company, entered into a partnership agreement with SK Biopharmaceuticals to accelerate research and development into novel therapeutic compounds that target miRNAs.

Key market players are involved in the development of new tools, instruments, and kits with high specificity and reproducibility, which is fueling the market growth. For instance, in October 2019, TriLink BioTechnologies introduced two primer sets for its CleanTag kit. Thermo Fisher Scientific's sequencer platform can prepare small RNA libraries using these new Ion Torrent Convert barcode primer sets. Such launches are expected to boost market growth.

miRNA Sequencing And Assay Market Report Highlights:

• The products segment dominated the market with the largest revenue share of around 80% in 2022. This is due to the presence of several key companies that offer a broad range of consumables, kits, and instruments for specific applications
• By technology, the sequencing by synthesis segment dominated the market with the largest revenue share of over 32% in 2022. This is due to its fast turnaround time, high sensitivity, and high throughput. Moreover, it plays a key role in the mutation detection of tumor tissue, which helps to develop personalized therapies
• By workflow, the sequencing segment dominated the market with the largest revenue share of over 50% in 2022 and is expected to grow at the fastest CAGR of 14.1% over the forecast period as it is the most important step in the workflow. It has become a key research tool in biological research and several disease diagnoses
• By application, the cancer segment dominated the market and accounted for the largest revenue share of over 35% in 2022. Several ongoing research in cancer using miRNA as a biomarker to study the prognosis and diagnosis of cancer to develop new therapies is contributing to the segment growth
• By end-use, the research and academic institutes segment dominated the market and accounted for the largest revenue share of over 50% in 2022. The growth is attributed to the increased R&D studies conducted by academic institutes using miRNA sequencing techniques
• Asia Pacific is expected to grow at the fastest CAGR of 15.4% during the forecast period. This is due to the growing healthcare infrastructure, significant targeted population, and high unmet clinical needs

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product & Service
  • 1.1.2. Technology
  • 1.1.3. Workflow
  • 1.1.4. Application
  • 1.1.5. End use
  • 1.1.6. Regional scope
  • 1.1.7. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product & service outlook
  • 2.2.2. Technology outlook
  • 2.2.3. Workflow outlook
  • 2.2.4. Application outlook
  • 2.2.5. End use outlook
  • 2.2.6. Regional outlook
• 2.3. Competitive Insights

Chapter 3. miRNA Sequencing And Assay Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
  • 3.3.2. Market restraint analysis
• 3.4. miRNA Sequencing And Assay Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. miRNA Sequencing And Assay: Product & Service Estimates & Trend Analysis

• 4.1. miRNA Sequencing And Assay Market: Key Takeaways
• 4.2. miRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
• 4.3. Products
  • 4.3.1. Products market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.3.2. Library preparation kits
    • 4.3.2.1. Library preparation kits market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.3.3. Sequencing consumables
    • 4.3.3.1. Sequencing consumables market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.3.4. Instruments
    • 4.3.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.4. Services
  • 4.4.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. MiRNA Sequencing And Assay: Technology Estimates & Trend Analysis

• 5.1. MiRNA Sequencing And Assay Market: Key Takeaways
• 5.2. MiRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
• 5.3. Sequencing by synthesis
  • 5.3.1. Sequencing by synthesis market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.4. Sequencing By Oligonucleotide Ligation and Detection (SOLiD)
  • 5.4.1. Sequencing by oligonucleotide ligation and detection (SOLiD) market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Nanopore Sequencing
  • 5.5.1. Nanopore sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.6. Sanger Sequencing
  • 5.6.1. Sanger sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.7. Single molecule real - time (SMRT) Sequencing
  • 5.7.1. Single molecule real - time (SMRT) sequencing market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. MiRNA Sequencing And Assay: Workflow Estimates & Trend Analysis

• 6.1. MiRNA Sequencing And Assay Market: Key Takeaways
• 6.2. MiRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
• 6.3. Library Preparation
  • 6.3.1. Library preparation market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.4. Sequencing
  • 6.4.1. Sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Data analysis & storage
  • 6.5.1. Data analysis & storage market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. MiRNA Sequencing And Assay: Application Estimates & Trend Analysis

• 7.1. MiRNA Sequencing And Assay Market: Key Takeaways
• 7.2. MiRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
• 7.3. Cancer
  • 7.3.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.4. Polyglutamine Diseases
  • 7.4.1. Polyglutamine diseases market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.5. Autoimmune Disease
  • 7.5.1. Autoimmune disease market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.6. Schizophrenia
  • 7.6.1. Schizophrenia market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. MiRNA Sequencing And Assay: End Use Estimates & Trend Analysis

• 8.1. MiRNA Sequencing And Assay Market: Key Takeaways
• 8.2. MiRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
• 8.3. Pharmaceutical & Biotechnology Industry
  • 8.3.1. Pharmaceutical & biotechnology industry market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.4. Research & Academic Institutes
  • 8.4.1. Research & academic institutes market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.5. Others
  • 8.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. MiRNA Sequencing And Assay: Regional Estimates & Trend Analysis

• 9.1. Regional Outlook
• 9.2. MiRNA Sequencing And Assay Market by Region: Key Takeaway
• 9.3. North America
  • 9.3.1. North America market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
• 9.4. Europe
  • 9.4.1. Europe market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.4.2. UK
    • 9.4.2.1. UK market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.4.4. France
    • 9.4.4.1. France market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.4.7. Sweden
    • 9.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.4.8. Norway
    • 9.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.4.9. Denmark
    • 9.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.5.3. China
    • 9.5.3.1. China market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.5.4. India
    • 9.5.4.1. India market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.5.5. Australia
    • 9.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.5.7. South Korea
    • 9.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.6.3. Mexico
    • 9.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.6.4. Argentina
    • 9.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
• 9.7. MEA
  • 9.7.1. MEA market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.7.3. South Africa
    • 9.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Market Participant Categorization
  • 10.2.1. Thermo Fisher Scientific, Inc.
    • 10.2.1.1. Company overview
    • 10.2.1.2. Financial performance
    • 10.2.1.3. Product benchmarking
    • 10.2.1.4. Strategic initiatives
  • 10.2.2. Illumina, Inc.
    • 10.2.2.1. Company overview
    • 10.2.2.2. Financial performance
    • 10.2.2.3. Product benchmarking
    • 10.2.2.4. Strategic initiatives
  • 10.2.3. QIAGEN
    • 10.2.3.1. Company overview
    • 10.2.3.2. Financial performance
    • 10.2.3.3. Product benchmarking
    • 10.2.3.4. Strategic initiatives
  • 10.2.4. PerkinElmer, Inc
    • 10.2.4.1. Company overview
    • 10.2.4.2. Financial performance
    • 10.2.4.3. Product benchmarking
    • 10.2.4.4. Strategic initiatives
  • 10.2.5. Abcam plc
    • 10.2.5.1. Company overview
    • 10.2.5.2. Financial performance
    • 10.2.5.3. Product benchmarking
    • 10.2.5.4. Strategic initiatives
  • 10.2.6. New England Biolabs
    • 10.2.6.1. Company overview
    • 10.2.6.2. Financial performance
    • 10.2.6.3. Product benchmarking
    • 10.2.6.4. Strategic initiatives
  • 10.2.7. Takara Bio Inc.
    • 10.2.7.1. Company overview
    • 10.2.7.2. Financial performance
    • 10.2.7.3. Product benchmarking
    • 10.2.7.4. Strategic initiatives
  • 10.2.8. Lexogen GmbH
    • 10.2.8.1. Company overview
    • 10.2.8.2. Financial performance
    • 10.2.8.3. Product benchmarking
    • 10.2.8.4. Strategic initiatives
  • 10.2.9. Norgen Biotek Corp.
    • 10.2.9.1. Company overview
    • 10.2.9.2. Financial performance
    • 10.2.9.3. Product benchmarking
    • 10.2.9.4. Strategic initiatives
  • 10.2.10. Maravai LifeSciences
    • 10.2.10.1. Company overview
    • 10.2.10.2. Financial performance
    • 10.2.10.3. Product benchmarking
    • 10.2.10.4. Strategic initiatives
  • 10.2.11. HTG Molecular Diagnostics, Inc.
    • 10.2.11.1. Company overview
    • 10.2.11.2. Financial performance
    • 10.2.11.3. Product benchmarking
    • 10.2.11.4. Strategic initiatives
  • 10.2.12. Meridian Bioscience, Inc.
    • 10.2.12.1. Company overview
    • 10.2.12.2. Financial performance
    • 10.2.12.3. Product benchmarking
    • 10.2.12.4. Strategic initiatives
  • 10.2.13. System Biosciences, LLC
    • 10.2.13.1. Company overview
    • 10.2.13.2. Financial performance
    • 10.2.13.3. Product benchmarking
    • 10.2.13.4. Strategic initiatives